BioWorld MedTech

July 15, 2015

DragonBio's remaining stake worth $73 million: Mindray finishes what it started with acquisition of remaining stake in Dragonbio

HONG KONG — Chinese medical device maker, Mindray Medical (Shenzhen) will acquire for $72.6 million the remaining 49% stake in Dragonbio Surgical Implant (Wuhan, China) that it did not acquire in an earlier deal. Read More

Inside the Beltway: FDA applies revised USP standards to draft guidance for heparin-bearing products

European TechTour Summit: Med-tech becoming increasingly 'personal' as technology improves

Attitude Adjustment needed: Beltway attitude change needed to spur biomedical investment

New Trade Association: Association forms to help smaller device firms promote value-based solutions

Financings: Opgen closes $6M funding headed up by Merck GHI

World in Review: Danish cancer center first in Europe to use Varian's Calypso transponders

Agreements/contracts: Multiple company collaboration to fight Type 2 diabetes battle

Briefly Noted

Products

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 9, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

GDE4 blockade promotes remyelination, study finds

BioWorld Science

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...